Carbetocin Acetate

Product Overview

Carbetocin Acetate is a long-acting synthetic analog of oxytocin, engineered for enhanced stability and prolonged pharmacological activity. As a critical peptide-based active pharmaceutical ingredient (API), it plays a vital role in modern obstetrics by effectively reducing the risk of postpartum hemorrhage—a leading cause of maternal mortality worldwide. Unlike natural oxytocin, Carbetocin Acetate demonstrates superior resistance to enzymatic degradation, enabling a single-dose administration with sustained therapeutic effect.

Specifications

Industrial Applications

Carbetocin Acetate is exclusively utilized in the pharmaceutical sector as an advanced uterotonic agent. Its primary application lies in the prevention and management of postpartum hemorrhage following cesarean or vaginal delivery. Due to its extended half-life and potent receptor affinity, it serves as a reliable alternative to conventional oxytocin regimens, particularly in resource-limited settings where cold-chain logistics are challenging. This peptide is formulated into sterile injectables under stringent GMP conditions and is not intended for cosmetic, nutraceutical, or non-medical use.

• Single-dose efficacy reduces clinical burden during postpartum care
• Thermally stable compared to native oxytocin
• Compliant with international pharmacopeial standards for peptide APIs
• Suitable for integration into WHO-recommended maternal health protocols